Abstract: Disclosed is an interface system including a first neuron cluster that outputs a first neuron signal including a first neuron request and first neuron data by performing a first arithmetic operation, and a first interface circuit that stores the first neuron data and outputs a first response, in response to the first neuron request. The first neuron cluster outputs a second neuron signal including a second neuron request and second neuron data by performing a second arithmetic operation, in response to the first response. Before the first data is transmitted to a second neuron cluster different from the first neuron cluster, the first interface circuit outputs the first response in response to a fact that the first neuron data is stored.

Abstract: The present invention provides a pharmaceutical composition for prevention or treatment of a stress disease and depression, the pharmaceutical composition be safely useable without toxicity and side effects by using an extract of leaves of Vaccinium bracteatum Thunb., which is natural resource of Korea, so that the reduction of manufacturing and production costs and the import substitution and export effects can be expected through the replacement of a raw material for preparation with a plant inhabiting in nature.

Abstract: A novel methylcyclohexane derivative, and a pharmaceutical composition including the same that is effective for the prevention or treatment of pain.

Abstract: There is provided a pharmaceutical composition for prevention and treatment of restenosis comprising isoxazole derivatives. The pharmaceutical composition includes a therapeutic effective amount of isoxazole derivatives represented by Formula 1 or pharmaceutically available salts thereof. The pharmaceutical composition may be useful to prevent and treat vascular restenosis since the pharmaceutical composition shows an anti-restenosis activity and accelerates the re-endothelization.

Abstract: A novel methylcyclohexane derivative, and a pharmaceutical composition including the same that is effective for the prevention or treatment of pain.

Abstract: An organic light emitting diode (OLED) display includes a display substrate including a display substrate including an organic light emitting element and a pixel defining layer having an opening defining a light emitting region of the organic light emitting element, an encapsulation substrate arranged opposite to the display substrate, a sealant arranged at an edge between the display substrate and the encapsulation substrate to seal a space between the display substrate and the encapsulation substrate from an outside and a filler filling the space between the display substrate and the encapsulation substrate, wherein the pixel defining layer has a thickness that varies by location, and a portion of the pixel defining layer closest to the sealant at edges of the display substrate having a thickness that is greater than a thickness of the pixel defining layer at all other portions of the display.

Abstract: Provided are an oxazole hydroxamic acid derivatives and pharmaceutically useful salt thereof as a histone deacetylase inhibitor. The oxazole hydroxamic acid derivative and pharmaceutically useful salt thereof, prepared in accordance with the present invention, can treat and/or prevent various cancers and inflammatory diseases caused by histone deacetylase.

Abstract: An organic light emitting diode (OLED) display and a method of manufacturing the same are provided. The OLED display includes: a substrate main body; an OLED that is formed on the substrate main body; a hydrophilic polymer layer that is formed on the substrate main body to cover the OLED and that includes a hydrophilic surface having an angle of contact within a range of larger than 0° and smaller than or equal to 50°; and an inorganic protective layer that is formed on the hydrophilic surface of the hydrophilic polymer layer.

Abstract: Disclosed herein are isoxazole derivatives and uses thereof. Serving as agonists of Wnt, the isoxazole derivatives activate Wnt/?-catenin signaling and thus can be used in the treatment and prevention of diseases related to the signal transduction. Also, pharmaceutically acceptable salts of the isoxazole derivatives are disclosed.

Abstract: There is provided a pharmaceutical composition for prevention and treatment of restenosis comprising isoxazole derivatives. The pharmaceutical composition includes a therapeutic effective amount of isoxazole derivatives represented by Formula 1 or pharmaceutically available salts thereof. The pharmaceutical composition may be useful to prevent and treat vascular restenosis since the pharmaceutical composition shows an anti-restenosis activity and accelerates the re-endothelization.

Abstract: An organic light emitting diode (OLED) display includes a display substrate including a display substrate including an organic light emitting element and a pixel defining layer having an opening defining a light emitting region of the organic light emitting element, an encapsulation substrate arranged opposite to the display substrate, a sealant arranged at an edge between the display substrate and the encapsulation substrate to seal a space between the display substrate and the encapsulation substrate from an outside and a filler filling the space between the display substrate and the encapsulation substrate, wherein the pixel defining layer has a thickness that varies by location, and a portion of the pixel defining layer closest to the sealant at edges of the display substrate having a thickness that is greater than a thickness of the pixel defining layer at all other portions of the display.

Abstract: Provided are an oxazole hydroxamic acid derivative and a pharmaceutically useful salt thereof as a histone deacetylase inhibitor The oxazole hydroxamic acid derivative and pharmaceutically useful salt thereof, prepared in accordance with the present invention, can treat and/or prevent various cancers and inflammatory diseases caused by histone deacetylase.

Abstract: Disclosed herein are isoxazole derivaties and uses thereof. Serving as agonists of Wnt, the isoxazole derivatives activate Wnt/?-catenin signaling and thus can be used in the treatment and prevention of diseases related to the signal transduction. Also, pharmaceutically acceptable salts of the isoxazole derivatives are disclosed.

Abstract: This invention is related to new ethylaziridine derivatives of formula (I) and their preparation. The compounds are useful synthetic intermediates for the synthesis of HIV protease inhibitors and oligopeptide mimetics.

Abstract: An apparatus supplying a clock in a multiline radio transmission system. The apparatus includes a clock generator for generating a clock from a reference signal, a clock branching module for receiving the clock generated from the clock generator and branching the clock, at least one clock patching module for receiving the branched clock from the clock branching module and patching the clock, and a clock distribution module for receiving the patched clock from the clock patching module and distributing the clock to each unit for receiving a clock of the multiline radio transmission system.

Abstract: A status information collection/control arrangement for a communication system has an operation processing unit including a plurality of ASICs and a monitoring control unit for monitoring and controlling the operation processing unit. Each of the ASICs generates status information and process control information from the monitoring control unit regarding the status information. The arrangement includes a dedicated interface ASIC for performing data communication with the monitoring control unit via a bidirectional data bus and processing an interface operation between the ASICs and the monitoring control unit in response to a unit select signal, address, read enable signal and write enable signal from the monitoring control unit.